Moderna, Inc. — Director's Dealing 2020

Mar 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-03-23

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-23	Common Stock	S	1273	$26.72	Disposed	2045267	Direct
2020-03-23	Common Stock	S	1603	$27.74	Disposed	2043664	Direct
2020-03-23	Common Stock	S	2124	$28.81	Disposed	2041540	Direct
2020-03-24	Common Stock	S	3238	$24.95	Disposed	2038302	Direct
2020-03-24	Common Stock	S	1562	$25.59	Disposed	2036740	Direct
2020-03-24	Common Stock	S	200	$26.89	Disposed	2036540	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $27.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.37 to $28.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.42 to $29.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.37 to $25.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.40 to $26.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.76 to $27.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.